This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 Oct;188(4):1235.

doi: 10.1016/j.juro.2012.06.079. Epub 2012 Aug 17.

Re: Comparison of the clinical efficacy of medical treatment of symptomatic benign prostatic hyperplasia between normal and obese patients

Steven A Kaplan

PMID: 22971392
DOI: 10.1016/j.juro.2012.06.079

Comment

Re: Comparison of the clinical efficacy of medical treatment of symptomatic benign prostatic hyperplasia between normal and obese patients

Steven A Kaplan. J Urol. 2012 Oct.

. 2012 Oct;188(4):1235.

doi: 10.1016/j.juro.2012.06.079. Epub 2012 Aug 17.

Author

Steven A Kaplan

PMID: 22971392
DOI: 10.1016/j.juro.2012.06.079

No abstract available

PubMed Disclaimer

Comment on

Comparison of the clinical efficacy of medical treatment of symptomatic benign prostatic hyperplasia between normal and obese patients.
Lee SH, Oh CY, Park KK, Chung MS, Yoo SJ, Chung BH. Lee SH, et al. Asian J Androl. 2011 Sep;13(5):728-31. doi: 10.1038/aja.2011.5. Epub 2011 Apr 18. Asian J Androl. 2011. PMID: 21499281 Free PMC article.

Similar articles

Estrogen suppression as a pharmacotherapeutic strategy in the medical treatment of benign prostatic hyperplasia: evidence for its efficacy from studies with mepartricin.
Boehm S, Nirnberger G, Ferrari P. Boehm S, et al. Wien Klin Wochenschr. 1998 Dec 11;110(23):817-23. Wien Klin Wochenschr. 1998. PMID: 10025034 Review.
Maintenance of clinical efficacy with finasteride therapy for 24 months in patients with benign prostatic hyperplasia. The Finasteride Study Group.
Stoner E. Stoner E. Arch Intern Med. 1994 Jan 10;154(1):83-8. Arch Intern Med. 1994. PMID: 7505563 Clinical Trial.
alpha-blockade in the treatment of symptomatic benign prostatic hyperplasia.
Eri LM, Tveter KJ. Eri LM, et al. J Urol. 1995 Sep;154(3):923-34. J Urol. 1995. PMID: 7543612 Review.
A clinical outcomes and cost analysis comparing photoselective vaporization of the prostate to alternative minimally invasive therapies and transurethral prostate resection for the treatment of benign prostatic hyperplasia.
Stovsky MD, Griffiths RI, Duff SB. Stovsky MD, et al. J Urol. 2006 Oct;176(4 Pt 1):1500-6. doi: 10.1016/j.juro.2006.06.064. J Urol. 2006. PMID: 16952668
[Clinical results of interstitial laser coagulation for benign prostatic hyperplasia using diode laser].
Kin S, Kanatani I, Konami T. Kin S, et al. Hinyokika Kiyo. 1999 Nov;45(11):749-53. Hinyokika Kiyo. 1999. PMID: 10637736 Clinical Trial. Japanese.

See all similar articles

Publication types

Actions

LinkOut - more resources

Full Text Sources